162 Results for "

interferon alpha

" in MedChemExpress (MCE) Product Catalog:
Products (162)

162 Results for "interferon alpha" in MCE Product Catalog:

29
29 Publications Verification
Cat. No.: HY-W063968
CAS No.: 691868-88-9
Synonyms: CDM-3008; RO4948191
Target:  

IFNAR JAK STAT HCV HBV

Domaines de recherche:  

Infection

RO8191 (CDM-3008), an imidazonaphthyridine compound, is an orally active and potent interferon (IFN) receptor agonist. RO8191 directly binds to IFNα/β receptor 2 (IFNAR2) and activates IFN-stimulated genes (ISGs) expression and JAK/STAT phosphorylation. RO8191 shows antiviral activity against both HCV and EMCV with an IC50 of 200 nM for HCV replicon . RO8191 is a cccDNA modulator (CDM) through interferon-like activity and has anti-HBV activity .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-P7022
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNA2; IFN-alpha-2; interferon alpha 2; IFNA2B; IFN-alphaA; LeIF A; IFNA; interferon alpha 2a; alpha-2a interferon; interferon alpha-A; interferon alpha 2b; interferon 1AB4; interferon alpha A; IFNA2C; interferon alpha-2; IFNA2A
Species:  
Source:  
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-P7023
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNA2; IFN-alpha-2; interferon alpha 2; IFNA2B; IFN-alphaA; LeIF A; IFNA; interferon alpha 2a; alpha-2a interferon; interferon alpha-A; interferon alpha 2b; interferon 1AB4; interferon alpha A; IFNA2C; interferon alpha-2; IFNA2A
Species:  
Source:  
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-112732
CAS No.: 51321-79-0
Target:  

Apoptosis

Domaines de recherche:  

Metabolic Disease Cancer

Sparfosic acid, a DNA antimetabolite agent, is a potent inhibitor of aspartate transcarbamoyl transferase, the enzyme catalyzing the second step of de novo pyrimidine biosynthesis. Sparfosic acid synergistically enhances the cytotoxicity of a combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN) against human colon cancer cell lines .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-112732B
CAS No.: 70962-66-2
Pureté:  ≥98.0%
Target:  

Apoptosis

Domaines de recherche:  

Metabolic Disease Cancer

Sparfosic acid trisodium is a DNA antimetabolite agent and a potent inhibitor of aspartate transcarbamoyl transferase. Aspartate transcarbamoyl transferase catalyzes the second step of de novo pyrimidine biosynthesis. Sparfosic acid trisodium synergistically enhances the cytotoxicity of a combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN) against human colon cancer cell lines .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P7544
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNA2; IFN-alpha-2; interferon alpha 2; IFNA2B; IFN-alphaA; LeIF A; IFNA; interferon alpha 2a; alpha-2a interferon; interferon alpha-A; interferon alpha 2b; interferon 1AB4; interferon alpha A; IFNA2C; interferon alpha-2; IFNA2A
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-118250
CAS No.: 1207629-49-9
Pureté:  99.85%
Domaines de recherche:  

Inflammation/Immunology

GSK2245035 is a highly potent and selective intranasal Toll-Like receptor 7 (TLR7) agonist with preferential Type-1 interferon (IFN)-stimulating properties. GSK2245035 has pEC50s of 9.3 and 6.5 for IFNα and TFNα. GSK2245035 effectively suppresses allergen-induced Th2 cytokine production in human peripheral blood cell cultures. GSK2245035 is used for asthma .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-150217
CAS No.: 1234402-77-7
Synonyms: ODN 10101
Domaines de recherche:  

Infection Inflammation/Immunology

CpG ODN 10101 (ODN 10101; CPG 10101) is a selective agonist targeting TLR9, a synthetic oligodeoxynucleotide modified with phosphate thioester. CpG ODN 10101 activates B cells and plasmacytoid dendritic cells (pDCs), inducing the production of cytokines and chemokines such as interferon-IFN-α, interferon-inducible protein IP-10, and 2'5'-oligoadenylate synthase (2'5'-OAS), regulating innate immunity and promoting Th1 adaptive immune responses. CpG ODN 10101 also possesses antiviral properties and enhances vaccine immunogenicity, making it suitable as an immunomodulator and vaccine adjuvant for vaccine development in chronic hepatitis C and infectious diseases such as melioidosis, pertussis, and respiratory syncytial virus (RSV) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W011890
CAS No.: 38609-97-1
Domaines de recherche:  

Inflammation/Immunology Cancer

Cridanimod is a potent progesterone receptor (PR) activator mediated through induction of IFNα and IFNβ expression. Cridanimod is a small-molecule immunomodulator and interferon inducer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P73246
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IFNA2; IFN-alpha-2; interferon alpha 2; IFNA2B; IFN-alphaA; LeIF A; IFNA; interferon alpha 2a; alpha-2a interferon; interferon alpha-A; interferon alpha 2b; interferon 1AB4; interferon alpha A; IFNA2C; interferon alpha-2; IFNA2A
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72796
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNA1; interferon alpha-1; interferon alpha 1; interferon alpha-D; IFN-alphaD; interferon-alpha1; IFN-alpha; IFN-alpha-1; IFNA13; LeIF D; IFNA@; interferon alpha-1/13; IFL; IFN-alpha-1/13; IFN; IFN-alpha 1b; interferon alpha 1b
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70241
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNA1; interferon alpha-1; interferon alpha 1; interferon alpha-D; IFN-alphaD; interferon-alpha1; IFN-alpha; IFN-alpha-1; IFNA13; LeIF D; IFNA@; interferon alpha-1/13; IFL; IFN-alpha-1/13; IFN; IFN-alpha 1b; interferon alpha 1b
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P700183AF
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNA1; interferon alpha-1; interferon alpha 1; interferon alpha-D; IFN-alphaD; interferon-alpha1; IFN-alpha; IFN-alpha-1; IFNA13; LeIF D; IFNA@; interferon alpha-1/13; IFL; IFN-alpha-1/13; IFN; IFN-alpha 1b; interferon alpha 1b
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72243
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IFNA14; interferon alpha-14; interferon alpha 14; interferon alpha-H; IFN-alphaH; IFN-alpha-14; LEIF2H; LeIF H; interferon Lambda-2-H; interferon, alpha 14
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P76401
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IFNA14; interferon alpha-14; interferon alpha 14; interferon alpha-H; IFN-alphaH; IFN-alpha-14; LEIF2H; LeIF H; interferon Lambda-2-H; interferon, alpha 14
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72613
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNAR2; IFN-R-2; Prev. IFNABR; interferon-alpha/Beta Receptor Beta Chain; interferon alpha/Beta Receptor 2; Human interferon alpha/Beta Receptor; Type I interferon Receptor 2; IFN-alpha Binding Protein; interferon (alpha, Beta And Omega) Receptor 2; Inter
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-173425
CAS No.: 2912492-05-6
Domaines de recherche:  

Inflammation/Immunology

STING-IN-15 is an orally active STING inhibitor, with an IC50 of 116 nM against h-STING and an IC50 of 96.3 nM against m-STING. STING-IN-15 inhibits the STING signaling pathway in cells, reduces the secretion of IFN-β and IP-10, downregulates the expression of ISG15, ISG56 and TNF-α, and suppresses the phosphorylation of TBK1/IRF3. STING-IN-15 alleviates systemic and renal inflammation induced by STING agonists in mice, reduces tissue damage and the expression of interferon pathway genes, and inhibits spontaneous tissue inflammation in mice. STING-IN-15 can be used for the research of acute kidney injury and autoimmune/inflammatory diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P5522A
Synonyms: L-Ala-γ-D-Glu-meso-diaminopimelic acid dihydrochloride
TriDAP dihydrochloride (L-Ala-γ-D-Glu-meso-diaminopimelic acid dihydrochloride) is a NOD1 agonist with a Kd value of 34.5 μM. TriDAP dihydrochloride enhances the binding of NOD1-RICK, promotes RICK phosphorylation, and activates the NF-κB, TAK1, MEK/ERK, p38 and interferon response pathways. TriDAP dihydrochloride downregulates Runx2 via increasing ubiquitination and reduces trabecular bone parameters. TriDAP dihydrochloride decreases IκBα levels and increases p65 levels. TriDAP dihydrochloride induces the secretion of proinflammatory mediators IL-8 and prostaglandins, triggers tissue inflammation and innate immune activation, and inhibits SARS-CoV-2 replication in lung epithelial cells. TriDAP dihydrochloride increases the RANKL/OPG ratio in mice, reduces bone mass and enhances osteoclast activity, and inhibits new bone formation by decreasing the mineralization deposition rate in mice. TriDAP dihydrochloride can be used in research related to pulpitis, chronic ulcerative colitis, Crohn's disease and SARS-CoV-2 infection .
loading...
    loading...
Cat. No.: HY-P99219
CAS No.: 1006877-41-3
Synonyms: MEDI-545; MDX 1103

Target:  

IFNAR

Domaines de recherche:  

Inflammation/Immunology

Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research .
loading...
    loading...
Cat. No.: HY-148511A
Pureté:  90.20%
Synonyms: CMP-001 sodium
Domaines de recherche:  

Cancer

Vidutolimod sodium is a CpG-A oligodeoxynucleotide. Vidutolimod sodium is a Toll-like receptor 9 (TLR9) agonist, which activates plasmacytoid dendritic cells (pDCs) and triggers interferon alpha (IFNα) release, leading to a cascade of anti-tumor immune effects.
loading...
    loading...